title: The 'immunologic advantage' of HIV-exposed seronegative individuals.
authors.forename: Masaaki
authors.initials: M
authors.lastname: Miyazawa
authors.forename: Lucia
authors.initials: L
authors.lastname: Lopalco
authors.forename: Francesco
authors.initials: F
authors.lastname: Mazzotta
authors.forename: Sergio
authors.initials: S
authors.lastname: Lo Caputo
authors.forename: Francisco
authors.initials: F
authors.lastname: Veas
authors.forename: Mario
authors.initials: M
authors.lastname: Clerici
mesh_terms: D004198:Disease Susceptibility; D015483:HIV Antibodies / Q000096:biosynthesis; D018023:HIV Seronegativity / Q000235:genetics / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007113:Immunity, Innate; D009626:Terminology as Topic
chemical_list: D015483:HIV Antibodies